Bologna

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Glioblastoma1 trial

Phase

• Phase 32 trials

Status

• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1 trial

Closed trials

• Withdrawn

  A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies

  NCT06205290· Phase 3· Juno Therapeutics, Inc., a Bristol-Myers Squibb Company· Source

• Completed

  An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

  NCT02667587· Phase 3· Bristol-Myers Squibb· Source